Page last updated: 2024-09-03

13-azaprostanoic acid and dazoxiben

13-azaprostanoic acid has been researched along with dazoxiben in 2 studies

Compound Research Comparison

Studies (13-azaprostanoic acid)	Trials (13-azaprostanoic acid)	Recent Studies (post-2010) (13-azaprostanoic acid)	Studies (dazoxiben)	Trials (dazoxiben)	Recent Studies (post-2010) (dazoxiben)
42	0	0	292	27	10

Protein Interaction Comparison

Protein	Taxonomy	dazoxiben (IC50)
Aromatase	Homo sapiens (human)	1.1
Thromboxane-A synthase	Homo sapiens (human)	0.5985
Thromboxane-A synthase	Rattus norvegicus (Norway rat)	0.9512

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cassina, G; Livio, M; Macconi, D; Morelli, C; Morzenti, G; Remuzzi, G	1
Bertelé, V; Castagnoli, MN; Cerletti, C; de Gaetano, G; Rajtar, G	1

Other Studies

2 other study(ies) available for 13-azaprostanoic acid and dazoxiben

Article	Year
Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism. Laboratory investigation; a journal of technical methods and pathology, 1985, Volume: 52, Issue:2 Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Catechols; Chromatography, Thin Layer; Cyclooxygenase Inhibitors; Humans; Imidazoles; In Vitro Techniques; Lipoxygenase Inhibitors; Masoprocol; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Prostanoic Acids; Quinacrine; Radioimmunoassay; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase	1985
Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. Biochemical pharmacology, 1985, Feb-01, Volume: 34, Issue:3 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dinoprost; Dinoprostone; Drug Synergism; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Prostanoic Acids; Thromboxane B2; Thromboxane-A Synthase	1985

Article

Year

Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.

Laboratory investigation; a journal of technical methods and pathology, 1985, Volume: 52, Issue:2

Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Catechols; Chromatography, Thin Layer; Cyclooxygenase Inhibitors; Humans; Imidazoles; In Vitro Techniques; Lipoxygenase Inhibitors; Masoprocol; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Prostanoic Acids; Quinacrine; Radioimmunoassay; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase

1985

Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.

Biochemical pharmacology, 1985, Feb-01, Volume: 34, Issue:3

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dinoprost; Dinoprostone; Drug Synergism; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Prostanoic Acids; Thromboxane B2; Thromboxane-A Synthase

1985